Loading, please wait...
***Please note: this course is 1 hour of CE credit***
To access the video after registration, please click the "+" sign to the left of the program title listed below in light blue.
CE Hours
2.00
CE Units
0.200
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
|
Requirements for CE Credit
To receive credit you must watch the recorded webinar and complete the post-test. You must receive a minumum of 70% on the post-test at which time you will be prompted to complete a program evaluation form.
**To Register for this Program: Select your fee type and then hit "Purchase Now" at the bottom of your screen.
Below is a description of the fee types:
- TTUHSC JHH SOP Faculty
- Full-time Jerry H. Hodge School of Pharmacy (JHH SOP) Faculty
- TTUHSC Adjunct Preceptor
- JHH SOP Adjunct Preceptor for Experiential Rotations
- TTUHSC JHH SOP Alumni
- JHH SOP Alumni
- TTUHSC JHH SOP Alumni - TTUHSC Alumni Association Member
- JHH SOP Alumni that have paid alumni dues to TTUHSC, but not a preceptor for JHH SOP. Click here to become a TTUHSC Alumni Association member
- Pharmacist
- Non-JHH SOP Faculty, Adjunct Faculty, or Alumni
- Pharmacy Technician
Individuals will be audited to ensure they select the correct fee type. Those found to have selected an inappropriate fee type will have their CPE credits removed from their NABP eProfile.
|
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
Objectives
- Describe the clinical presentation of someone who meets criteria for Major Depressive Disorder (MDD) and Treatment Resistant Depression (TRD).
- Discuss the pharmacology of ketamine/esketamine, dextromethorphan, brexanolone/zuranolone and psilocybin.
- Identify which patients may be good candidates for the specific agents discussed in this presentation.
- Provide appropriate counseling and monitoring to patients prescribed alternative medications for depression.
Speaker(s)/Author(s)
|
Monica Mathys, Pharm.D., BCGP, BCPP Disclosure : The presenter has no relevant conflict of interest related to this presentation. The speaker has no relevant financial relationship(s) with ineligible companies to disclose with regard to this presentation. |
Activity Number
0096-0000-23-116-H01-P
Release Date:
Sep 6, 2023
Credit Expiration Date:
Sep 6, 2026
CE Hours
1.00
Fee
$10.00
Objectives
- Describe the clinical presentation of someone who meets criteria for Major Depressive Disorder and Treatment Resistant Depression.
- Discuss the dosing formulations of ketamine, esketamine, brexanolone, and dextromethorphan.
- Summarize in which situations alternative medications for depression might be prescribed.
Speaker(s)/Author(s)
|
Monica Mathys, Pharm.D., BCGP, BCPP Disclosure : The presenter has no relevant conflict of interest related to this presentation. The speaker has no relevant financial relationship(s) with ineligible companies to disclose with regard to this presentation. |
Activity Number
0096-0000-23-117-H01-T
Release Date:
Sep 6, 2023
Credit Expiration Date:
Sep 6, 2026
CE Hours
1.00
Fee
$10.00